The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Gliolan

30 milligram(s)/millilitre Powder for oral solution

medac Gesellschaft für klinische Spezialpräparate mbHEU/1/07/413/1-3

Main Information

Trade NameGliolan
Active Substances5-aminolevulinic acid hydrochloride
Strength30 milligram(s)/millilitre
Dosage FormPowder for oral solution
Licence Holdermedac Gesellschaft für klinische Spezialpräparate mbH
Licence NumberEU/1/07/413/1-3

Group Information

ATC CodeL01XD Sensitizers used in photodynamic/radiation therapy
L01XD04 aminolevulinic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued07/09/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back